Testing for prostate cancer has declined after a recommendation in 2012 said it shouldn't be routine.
November 17, 2015 A decrease in PSA testing came after a controversial recommendation against routine screening. As a result, many fewer cases of the most common cancer to hit men are being diagnosed, research finds.
<iframe src="http://www.npr.org/player/embed/456201282/456395511" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Poet Pablo Neruda talks with reporters Oct. 21, 1971, in Paris after being awarded that year's Nobel Prize for Literature.
November 6, 2015 Neruda's death in 1973 was attributed to prostate cancer. Now, 42 years later, the Chilean government says the Nobel laureate may have been killed in the aftermath of a coup.
Almost 18 percent of Americans are Hispanic, and their experiences with cancer vary greatly.
September 16, 2015 Hispanics are less likely to get cancer than non-Hispanic whites, but they're more susceptible to gallbladder, liver and stomach cancer. And country of origin affects cancer risk, too.
The active ingredient in Propecia, a baldness remedy approved by the Food and Drug Administration in 1997, is showing new promise as a way to prevent some prostate cancers.
August 14, 2013 Doctors have debated for years whether a drug that curbed the growth of some prostate cancers caused more serious ones to grow faster. Now, a long-term study calms those fears and raises the possibility that a cheap, generic pill could be used reduce prostate cancer risk.
<iframe src="http://www.npr.org/player/embed/212046489/212052975" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Sally O'Neill decided to have a double mastectomy rather than "do a wait-and-see."
August 5, 2013 The question of how to treat ductal carcinoma in situ is roiling the medical profession, and making for tough choices for women. The condition may never become invasive cancer. But some women choose to have mastectomies rather than live with uncertainty.
<iframe src="http://www.npr.org/player/embed/208239545/209097968" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
At least they're talking.
July 11, 2013 Doctors are supposed to engage patients in shared decision-making over complex choices like whether or not to get tested for prostate cancer. But most doctors don't do that, a survey finds. And efforts to train doctors to do a better job haven't been all that successful.
A billboard advertising robotic surgery hangs outside Boston's Fenway Park in 2009. Hospitals and doctors have heavily promoted robotic surgery.
June 26, 2013 Men with low-grade prostate cancer are choosing robotic surgery and other expensive treatments, even though they probably don't need treatment at all, a study says. Less testing and waiting before deciding to treat would reduce harmful side effects in many cases.
June 10, 2013 Replacing some dietary carbohydrates with vegetable fats may help keep prostate cancer from spreading. That's the word from a study of more than 4,500 men that looked at the effects of dietary changes after their initial diagnosis.
Terry Dyroff, of Silver Spring, Md., had a PSA blood test that led to a prostate biopsy. The biopsy found no cancer but did give him a life-threatening infection.
Jose Luis Magana/AP
May 3, 2013 The American Urological Association released new guidelines that, if they're heeded, would dramatically reduce the ranks of men who would be candidates for PSA testing. The prostate-specific antigen test can catch cancer early, but it frequently gives false alarms.
When is the right time to check the PSA box?
February 5, 2013 Testing for prostate cancer may not get any less confusing anytime soon. But researchers say the much-maligned PSA screening test is worthwhile if it's used for the right men at the right time.
Radiation therapist Jean Etienne holds a range compensator, which shapes the depth to which the proton beam enters a patient's body to target a tumor.
October 29, 2012 Proton therapy can be targeted much more precisely than regular radiation. The hope is that it translates into far fewer side effects, such as impotence and incontinence. But it also costs twice as much as regular radiation. And there's no proof it's more effective — it could potentially be worse, say some radiation experts.
<iframe src="http://www.npr.org/player/embed/163635298/163845729" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
Dr. Karen Lindsfor, a radiologist at the University of California, Davis, Medical Center, reads a mammogram in Sacramento, Calif.
September 6, 2012 There are conflicting guidelines on when women should get mammograms and mounting questions on when the PSA blood test for prostate cancer is worthwhile. We asked how people are sorting things out.
Surgery for prostate cancer shouldn't be an automatic choice, a new study says.
July 18, 2012 A study of more than 700 men with prostate cancer found no difference in rates of death among men who had their prostates surgically removed compared to those who didn't. The findings suggest that men with low-risk cancers could forgo surgery.
May 28, 2012 A federal task force's recommendations against routine blood tests for prostate cancer raises big questions about how to interpret medical evidence and what role expert panels should play in how doctors practice. But those questions aren't easy to answer.
<iframe src="http://www.npr.org/player/embed/153879847/153883324" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
May 24, 2012 Johns Hopkins researcher round that nearly three-quarters of primary care doctors they surveyed said their patients expected regular PSA screening to continue. The findings suggest there will be
NPR thanks our sponsors
Become an NPR sponsor